It’s only fair to share… FDA approves Admelog, the first short-acting “follow-on” insulin product to treat diabetes The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes …